SURF
Goldman Sachs’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-633,569
| Closed | -$443K | – | 5233 |
|
|
2023
Q1 | $443K | Sell |
633,569
-450,898
| -42% | -$315K | ﹤0.01% | 4135 |
|
|
2022
Q4 | $889K | Sell |
1,084,467
-183,780
| -14% | -$151K | ﹤0.01% | 3757 |
|
|
2022
Q3 | $1.32M | Buy |
1,268,247
+198,336
| +19% | +$206K | ﹤0.01% | 3664 |
|
|
2022
Q2 | $1.76M | Buy |
1,069,911
+215,312
| +25% | +$353K | ﹤0.01% | 3535 |
|
|
2022
Q1 | $2.51M | Buy |
854,599
+140,980
| +20% | +$414K | ﹤0.01% | 3393 |
|
|
2021
Q4 | $3.41M | Sell |
713,619
-486,270
| -41% | -$2.32M | ﹤0.01% | 3099 |
|
|
2021
Q3 | $9.08M | Buy |
1,199,889
+432,647
| +56% | +$3.28M | ﹤0.01% | 2350 |
|
|
2021
Q2 | $5.72M | Buy |
767,242
+253,159
| +49% | +$1.89M | ﹤0.01% | 2678 |
|
|
2021
Q1 | $4.01M | Buy |
514,083
+494,073
| +2,469% | +$3.85M | ﹤0.01% | 2834 |
|
|
2020
Q4 | $185K | Buy |
20,010
+5,386
| +37% | +$49.8K | ﹤0.01% | 4299 |
|
|
2020
Q3 | $101K | Sell |
14,624
-11,824
| -45% | -$81.7K | ﹤0.01% | 4230 |
|
|
2020
Q2 | $173K | Buy |
26,448
+15,091
| +133% | +$98.7K | ﹤0.01% | 4038 |
|
|
2020
Q1 | $21K | Sell |
11,357
-8,817
| -44% | -$16.3K | ﹤0.01% | 4354 |
|
|
2019
Q4 | $38K | Sell |
20,174
-10,634
| -35% | -$20K | ﹤0.01% | 4223 |
|
|
2019
Q3 | $44K | Sell |
30,808
-17,939
| -37% | -$25.6K | ﹤0.01% | 4140 |
|
|
2019
Q2 | $137K | Sell |
48,747
-16,586
| -25% | -$46.6K | ﹤0.01% | 3951 |
|
|
2019
Q1 | $312K | Buy |
65,333
+23,517
| +56% | +$112K | ﹤0.01% | 3729 |
|
|
2018
Q4 | $177K | Buy |
41,816
+13,947
| +50% | +$59K | ﹤0.01% | 3773 |
|
|
2018
Q3 | $305K | Sell |
27,869
-30,399
| -52% | -$333K | ﹤0.01% | 3662 |
|
|
2018
Q2 | $950K | Buy |
+58,268
| New | +$950K | ﹤0.01% | 3228 |
|